ALMZX
Price
$32.27
Change
-$0.18 (-0.55%)
Updated
Jun 22 closing price
Net Assets
58.98M
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

ALMZX vs VMGMX

ALMZX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
ALMZX vs. VMGMX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMZX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. ALMZX (59M). VMGMX pays higher dividends than ALMZX: VMGMX (0.62) vs ALMZX (0.00). ALMZX was incepted earlier than VMGMX: ALMZX (10 years) vs VMGMX (15 years). ALMZX (1.06) is less costly to investors than VMGMX (0.07). ALMZX is a more actively managed with annual turnover of: 91.15 vs. VMGMX (17.00). VMGMX has a lower initial minimum investment than ALMZX: VMGMX (3000) vs ALMZX (500000). ALMZX annual gain was more profitable for investors over the last year : 21.81 vs. VMGMX (12.44). VMGMX return over 5 years is better than : 31.82 vs. ALMZX (-32.25).
ALMZXVMGMXALMZX / VMGMX
Total Expense Ratio0.790.071,129%
Annual Report Gross Expense Ratio1.060.071,514%
Fund Existence10 years15 years-
Gain YTD9.1499.69494%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets59M33.8B0%
Annual Yield % from dividends0.000.62-
Returns for 1 year21.8112.44175%
Returns for 3 years65.2255.17118%
Returns for 5 years-32.2531.82-101%
Returns for 10 yearsN/A212.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.47N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.11N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.25N/A
N/A
MFS Blended Research Value Equity R4